WEISEBERGER EDWARD J 4
4 · IGENE BIOTECHNOLOGY INC · Filed Jul 23, 2009
Insider Transaction Report
Form 4
WEISEBERGER EDWARD J
Chief Financial Officer
Transactions
- Conversion
Stock Options
2009-07-16$0.01/sh−4,500,000$27,000→ 0 totalExercise: $0.01From: 2009-07-16Exp: 2009-07-16→ Common Stock (3,979,697 underlying) - Exercise/Conversion
Common Stock
2009-07-16$0.01/sh+3,979,697$23,878→ 4,049,697 total
Footnotes (2)
- [F1](1) Pursuant to Company's Board of Directors Directive dated June 16, 2009, to repurchase employee Stock Options.
- [F2](2) Options converted pursuant to Company's Board of Directors Directive dated June 16, 2009.